An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Mehra
M R
MR
Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, Louisiana 70121, USA.
Ventura
H O
HO
Smart
F W
FW
Collins
T J
TJ
Ramee
S R
SR
Stapleton
D D
DD
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002216:Captopril / Q000627:therapeutic use; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000473:pathology / Q000517:prevention & control*; D004110:Diltiazem / Q000627:therapeutic use; D004656:Enalapril / Q000627:therapeutic use; D005260:Female; D016027:Heart Transplantation / Q000009:adverse effects / Q000000981:diagnostic imaging* / Q000473:pathology; D006801:Humans; D006965:Hyperplasia; D017706:Lisinopril / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use; D014184:Transplantation, Homologous; D017539:Tunica Intima / Q000187:drug effects / Q000473:pathology; D018084:Ultrasonography, Interventional; D014700:Verapamil / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D004656:Enalapril; D002216:Captopril; D014700:Verapamil; D017706:Lisinopril; D004110:Diltiazem; D009543:Nifedipine